Abstract

FY26 POTENT ANTICANCER: A NEW DRUG APPROACH IN CANCER TREATMENT

Ashok Kumar Sharma*, Dr. Vandana Sharma, Dr. Gyanendra Singh, Mukesh Sharma and Subhash Chand Pingolia

ABSTRACT

The main aim of the anticancer drugs is to eradicate the presence of malignant cells. The anticancer drugs are classified on the bases of their site of action on a point of biosynthesis pathway of important bio molecules. These classified as follows Alkylating agents, cytotoxic antibiotics, Anti metabolites, Microtubules inhibitors, and one of the advanced agents is the Osmium compounds. FY-26 is the extremely potent anticancer drug which acts as shutdown the cancer cells by exploiting weakness inherent in their energy generation. On the bases of research activity the parameters recorded that anticancer activity of FY- 26 is 49 times more potent than that of cisplatin. The results (Data) were obtained by National Cancer Institute USA in a tests conducted on 60 cell lines. Cancer cells are able to use their defective mitochondria for metabolic activity in their cytoplasm to generate energy, but the potent drug FY-26 inhibits their activity of generating energy, which causes the cancer cells to die. Mitochondria are the mini-power house for the cells. The power house of the cell (mitochondria) in cancer cells is mostly defective and as such they cannot produce sufficient energy for their growth.

Keywords: The main aim more potent than that of cisplatin.